Which has grown faster, HUM or MRNA?

Over the past five years, MRNA grew revenue faster — HUM at a 12.61% CAGR versus MRNA at 19.33%.

Does HUM or MRNA pay a bigger dividend?

HUM pays a dividend (0.94% yield), while MRNA has no payments in the available dividend history.

Is HUM or MRNA more profitable?

HUM runs the higher net margin — HUM at 0.88% versus MRNA at -141.43%.

How have HUM and MRNA total returns compared?

Over the past 5 years, HUM delivered 8.74% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Humana Inc. (HUM) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Humana Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

HUM

Humana Inc.

$45.61B

$379.86HealthcareDelayed quote: Aug 20, 2026, 3:09 PM EDT

MRNA

Moderna, Inc.

$53.88B

$135.80HealthcareDelayed quote: Aug 20, 2026, 3:10 PM EDT

Total return — HUM vs MRNA

growth of $100 · dividends reinvested · last 8y

HUM +23.2% (+2.6%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window

Log scale — wide-divergence pair

HUM MRNA

HUM vs MRNA: by the numbers

•MRNA is the larger company ($53.88B vs $45.61B market cap).
•HUM is profitable (0.88% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 12.61% CAGR).
•HUM pays a dividend (0.94% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	HUM	MRNA
P/E ratio	35.80	N/A
Forward P/E	41.31	N/A
P/S ratio	0.31	30.99
P/B ratio	2.38	10.21
EV / EBITDA	19.13	N/A
FCF yield	2.71%	N/A

Profitability

Metric	HUM	MRNA
Gross margin	13.65%	55.35%
Operating margin	1.39%	-158.13%
Net margin	0.88%	-141.43%
ROE	6.65%	-46.61%
ROIC	4.52%	-39.16%

Dividends

Metric	HUM	MRNA
Dividend yield	0.94%	N/A
Payout ratio	35.87%	N/A

Growth (annualized)

Metric	HUM	MRNA
Revenue CAGR (5Y)	12.61%	19.33%
EPS CAGR (5Y)	-17.27%	N/A
FCF CAGR (5Y)	-17.19%	N/A
Total return CAGR (5Y)	-0.80%	-14.22%

Frequently asked

Which has grown faster, HUM or MRNA?: Over the past five years, MRNA grew revenue faster — HUM at a 12.61% CAGR versus MRNA at 19.33%.
Does HUM or MRNA pay a bigger dividend?: HUM pays a dividend (0.94% yield), while MRNA has no payments in the available dividend history.
Is HUM or MRNA more profitable?: HUM runs the higher net margin — HUM at 0.88% versus MRNA at -141.43%.
How have HUM and MRNA total returns compared?: Over the past 5 years, HUM delivered 8.74% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio Humana dividend yield Humana ROE Moderna ROE Humana operating margin Moderna operating margin Humana revenue growth Moderna revenue growth Humana free cash flow Moderna free cash flow

Humana & Moderna appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.